All News

There is no right decision on if – or how – to reveal a cancer diagnosis in the workplace.

The FDA approval of Rylaze provides certain patients with leukemia and lymphoma with an on-demand treatment option since the only other approved therapy is currently undergoing a shortage.

A manager describes how an oncology nurse helps patients with cancer including her own mother.

The vaccine immune response monitoring platform can identify weak responses in patients with cancer and help determine the potential need for a booster shot.

Smoking cigarettes could lead to a four-fold increased risk of recurrence in patients with a previous diagnosis of non-muscle invasive bladder cancer.

“I could’ve implemented my bucket list, backed away from writing contracts, outlined my end-of-life wishes and prepared my children for my possible, impending demise,” writes a woman with ovarian cancer. “Instead, I signed a four-book publishing contract and started a full-time career as a fiction writer.”

As patients aged 65 or older receive a diagnosis of cancer, their treatment course and priorities may differ from their younger counterparts.

Despite this “obesity paradox,” doctors do not recommend gaining weight with hopes of improving cancer outcomes.

Researchers will examine innovative strategies to improve rates of colorectal cancer screenings in rural America.

The risk for under- or over-treatment for kidney cancer may be higher in women, in addition to Black and Hispanic patients.

Performing the recommended 150 minutes of physical activity per week could lead colorectal cancer survivors to “a happy and healthy life” post treatment, according to an expert.

A patient reflects on the comfort and grief within the world of metastatic breast cancer.

An analysis showed that glycemic index – but not glycemic load or total carbohydrate intake – significantly increased the risk of developing bladder cancer.

BRCA mutation carriers who used oral contraceptives for a long period of time had a lower risk of developing ovarian cancer, according to new research.

Fixed-duration Venclexta plus Gazyva produced longer remissions than chemoimmunotherapy in elderly patients with chronic lymphocytic leukemia and other comorbidities.

A cancer survivor describes how happy she was to return to the public swimming pool after getting her COVID-19 vaccine.

Katie Brown, senior vice president of survivorship and support for LUNGevity Foundation, wrote about a program for patients to gain knowledge from survivors.

One nurse describes how her colleague incorporates compassion into every aspect of her role as an oncology nurse.

A stage 3 bowel cancer survivor who recently found out she was in remission writes a poem about maintaining her identity despite cancer.

In its Speaking Out video series, on behalf of Aim at Melanoma, CURE ® spoke with Dr. Sunandana Chandra about emerging therapies in melanoma.

A modeling study demonstrated that breast cancer mortality may increase by 0.52% by 2030, but effects of delays during the COVID-19 pandemic may be mitigated by making up screenings sooner than later.

When patients with mantle cell lymphoma are discussing the use of a BTK inhibitor, they must consider what their insurance will cover, as well as current health complications and potential side effects.

The kinase inhibitor Rezurock was well tolerated in patients with chronic graft-versus-host disease who received up to five lines of prior systemic therapy.

A woman describes a nurse that helped her mother during her cancer journey, a time that can be described as an ‘unwanted and unwelcomed horror in their life.’

A woman shares the story of her journey with multiple cancer types, including the same one that her mother died from.

From Ashley Monroe’s blood cancer diagnosis to a CrossFit athlete’s inspiring cancer journey, here’s what’s happening in the cancer landscape this week.